Antineoplastic effect of β-elemene on prostate cancer cells and other types of solid tumour cells
Open Access
- 1 August 2010
- journal article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 62 (8) , 1018-1027
Abstract
Objectives: β-Elemene, a natural compound extracted from over 50 different Chinese medicinal herbs and plants, has been effective in the treatment of hyperplastic and proliferative disorders such as prostatic hypertrophy, hysteromyoma and neoplasms. Our previous studies have demonstrated that β-elemene exhibits strong inhibitory activity in ovarian cancer cells. The aim of the present study was to assess the effect of β-elemene on prostate cancer cells as well as other types of tumour cells and to determine whether the effect of β-elemene on prostate cancer cell death was mediated through the induction of apoptosis. Methods: The MTT assay was used to evaluate the ability of β-elemene to inhibit cellular proliferation in cancer cells. Cellular apoptosis was assessed by annexin V binding, TUNEL and ELISA-based assays. Caspase activity was measured using a caspases assay kit. The protein levels of Bcl-2, caspases, cytochrome c and poly(ADP-ribose) polymerase (PARP) were analysed by Western blotting. Key findings: Here, we showed that β-elemene had an antiproliferative effect on androgen-insensitive prostate carcinoma DU145 and PC-3 cells. Treatment with β-elemene also inhibited the growth of brain, breast, cervical, colon and lung carcinoma cells. The effect of β-elemene on cancer cells was dose dependent, with IC50 values ranging from 47 to 95 µg/ml (230–465 µm). TUNEL assay and flow cytometric analysis using annxin V/propidium iodide staining revealed that the percentage of apoptotic prostate cancer cells was increased by β-elemene in a dose- and time-dependent manner. Moreover, β-elemene exposure resulted in a decreased Bcl-2 protein level, increased cytochrome c release, and activated PARP and caspase-3, -7, -9, and -10 in prostate cancer cells. Conclusions: Overall, these findings suggest that β-elemene exerts broad-spectrum antitumour activity against many types of solid carcinoma and supports a proposal of β-elemene as a new potentially therapeutic drug for castration-resistant prostate cancer and other solid tumours.Keywords
This publication has 49 references indexed in Scilit:
- Molecular Mechanisms of Castration-Resistant Prostate Cancer ProgressionFuture Oncology, 2009
- Castration-resistant prostate cancer: Targeting androgen metabolic pathways in recurrent diseaseUrologic Oncology: Seminars and Original Investigations, 2009
- Maintenance of Intratumoral Androgens in Metastatic Prostate Cancer: A Mechanism for Castration-Resistant Tumor GrowthCancer Research, 2008
- Green tea polyphenols in the prevention of colon cancerFrontiers in Bioscience-Landmark, 2007
- Prostate Cancer Prevention Through Pomegranate FruitCell Cycle, 2006
- Pomegranate Extracts Potently Suppress Proliferation, Xenograft Growth, and Invasion of Human Prostate Cancer CellsJournal of Medicinal Food, 2004
- Epidermal Growth Factor Receptor-dependent, NF-κB-independent Activation of the Phosphatidylinositol 3-Kinase/Akt Pathway Inhibits Ultraviolet Irradiation-induced Caspases-3, -8, and -9 in Human KeratinocytesJournal of Biological Chemistry, 2003
- ApoptosisCell, 2002
- Mechanisms of ApoptosisThe American Journal of Pathology, 2000
- Proteases to die forGenes & Development, 1998